In silico Pharmacokinetics and Molecular Docking Studies of Lead Compounds Derived from Diospyros Mespiliformis
Pharmacokinetics and toxicity profile along with efficacy are the major determinants for successful drug development. This study was carried out to determine the pharmacokinetic profile, potential biological activities and toxicity of diospyrin, lupeol and plumbagin using in silico approaches. The Swiss ADME tool was used to calculate the molecular properties of the ligands based on Lipinski’s rule of five (5).All ligands in the present study satisfied the rule. Using the Swiss ADME tool, the pharmacokinetic profile of the compounds was evaluated. Protox-II server was used to predict the organ toxicities and toxicological end points of the ligands and their LD50. Plumbagin is found to have both mutagenicity and carcinogenicity. Lupeol and diospyrin are reported to be immunotoxic. Lupeol has LD50 of 2000mg/kg. Diospyrin and plumbagin have 16mg/kg. Swiss target prediction server was used to identify the various potential target. The target prediction suggests that plumbagin and lupeol have high preference for Microtubule-associated protein tau (MAPT). The best target for diospyrin was Aurora kinase A. Molecular docking study was conducted using AutoDock vina in The Python Prescription (PyRx) 0.8 virtual screening tool. Plumbagin and lupeol were docked against Microtubule associated protein tau. The dockings scores based on binding energy were; plumbagin -33.8 (kcal/mole) and lupeol -44.7 (kcal/mole). Diospyrin showed a binding energy of -10.7 (kcal/mole) against Aurora A kinase. Results in this study suggest that diospyrin may serve as an important aurora kinase inhibitor while lupeol and plumbagin may be useful in treatment of Alzheimer’s disease.
Amina I. Dirar, Ayman Y. Waddad, Magdi A. Mohamed, Malik S. Mohamed, Wadah J. Osman, Mona S. Mohammed, Mohamed A. A. Elbadawi (2016) ; In Silico Pharmacokinetics and molecular docking of three leads isolated from Tarconanthus camphoratus L, International Journal of Pharmacy and Pharmaceutical Sciences; 8(5); 975-1491
Anqun Tang, Keyu Gao, Laili Chu, Rui Zhang, Jing Yang and Junnian Zheng (2017) Aurora kinases: novel therapy targets in cancers, Oncotarget; 8(14); 23937-23954
Cirak Y, Furuncuoglu Y, Yapicier O, Aksu A, Cubukcu E (2015) ; Aurora A overexpression in breast cancer patients induces taxane resistance and results in worse prognosis; J BUON; 20(6); 1414–19.
Cross J.B, Thompson D.C, Rai BK, Baber J.C, Fan K.Y, Hu Y, Humblet C (2009) ; Comparison of several molecular docking programs: pose prediction and virtual screening accuracy; J Chem Inf Model; 49(6); 1455–1474
Dahlin, J. L., Inglese, J. & Walters, M. A (2015) ; Mitigating risk in academic preclinical drug discovery; Nature Rev. Drug Discov; 14(4); 279–294
Daina A., Michielin O., Zoete V (2017) ; SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules ; Sci. Rep; 7; 42717
Daina, A., Zoete, V. A (2016) ; BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules; ChemMedChem; 11(11): 1117–1121
David Gfeller, Aurélien Grosdidier, Aurélien Grosdidier, Matthias Wirth, Matthias Wirth, Antoine Daina, Olivier Michielin, Vincent Zoete (2014) ; SwissTargetPrediction: a web server for target prediction of bioactive small molecules; Nucleic Acids Research; 42 (Web Server issue):W32-8
Ferchichi I, Sassi Hannachi S, Baccar A, Marrakchi Triki R, Cremet J.Y, Ben Romdhane K, Prigent C, Ben Ammar El Gaaied A (2013); Assessment of Aurora A kinase expression in breast cancer: a tool for early diagnosis? ; Dis Markers; 34(2); 63–69.
Gaba Monika, Gaba Punam, Singh Sarbjot, and Gupta G. D (2010) An Overview On Molecular Docking, International Journal of Drug Development & Research ; 2(2) ; 219-231
Garneau-Tsodikova S (2010); Special series: natural products at the core of drug discovery. Biopolymers; 93(9); 753–4.
Ghosh, A., Das, B., Roy, A., Mandal, B. and Chandra, G., (2008); Antibacterial activity of some medicinal plant extracts; Journal of Natural Medicines ; 62(2); 259–262.
Gustafson, W.C., Meyerowitz, J.G., Nekritz, E.A., Chen, J., Benes, C., Charron, E., Simonds, E.F., Seeger, R., Matthay, K.K., Hertz, N.T., Eilers, M., Shokat, K.M., Weiss, W.A. (2014) ; Drugging MYCN through an allosteric transition in Aurora Kinase A ; Cancer Cell; 26(3); 414-427.
Hollenberg, P. F (2002) ; Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes; Drug Metab.Rev; 334(1-2); 17–35.
Kadavath, H., Jaremko, M., Jaremko, M., Biernat, J., Mandelkow, E., Zweckstetter, M. (2015) ; Folding of the Tau Protein on Microtubules; Angew Chem Int Ed Engl. ; 54(35); 10347-10351.
Kitchen D.B, Decornez H, Furr J.R, Bajorath J (2004); Docking and scoring in virtual screening for drug discovery: methods and applications. Nature reviews Drug discovery; 3 (11); 935-49
Levin G.M (2012); P-glycoprotein: why this drug transporter may be clinically important; Curr Psychiatry; 11(3); 38–40.
Lin JH, Yamazaki M (2003); Role of P-glycoprotein in pharmacokinetics: clinical implications; Clin Pharmacokinet; 42 (1); 59-98.
Lipinski C.A (2000) ; Drug- like properties and the causes of poor solubility and poor permeability; J.Pharmacol.Toxicol.Methods ; 44(1); 235–249.
Lounkine, E., Keiser, M.J., Whitebread, S., Mikhailov, D., Hamon, J., Jenkins, J.L., Lavan, P., Weber, E., Doak, A.K., Cˆot´e, S. et al (2012); Large-scale prediction and testing of drug activity on side-effect targets; Nature; 486(7403); 361–367.
Mohamed IE, El Nur EE, Choudhary MI, Khan SN. (2009); Bioactive natural products from two Sudanese medicinal plants Diospyros mespiliformis and Croton zambesicus Rec. Nat. Prod 2009; 3(4); 198-203
Montanari, F. & Ecker, G. F (2015) Prediction of drug-ABC-transporter interaction–Recent advances and future challenges; Adv. Drug Deliv. Rev; 86; 17–26.
Moroy G, Martiny VY, Vayer P, Villoutreix BO, Miteva MA (2012). Towards in silico structure-based ADMET prediction in drug discovery. Drug Discovery Today; 17: 44–55.
Morris, G.M. Huey, R. Lindstrom, W et al (2009) ; AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility; J. Comput Chem; 30(16); 2785-2791.
Nigg E.A (2001) ; Mitotic kinases as regulators of cell division and its checkpoints ; Nat Rev Mol Cell Biol; 2(1); 21–32
Pakomwit S, Prashant M, Paul T, Cross M, Coster MJ, Gorse AD, Krasavin M, Hofmann A (2015) ; Panel docking of small-molecule libraries: prospects to improve efficiency of lead compound discovery; Biotechnol Adv; 33(6 Pt 1); 941-947.
Patel, S., Vuillard, L., Cleasby, A., Murray, C.W., Yon, J.R. (2004); Apo and inhibitor complex structures of BACE (beta-secretase); J Mol Biol; 343(2); 407-16
Pelkonen O, Turpeinen M, Raunio H (2011) ; In vivo-in vitro-in silico pharmacokinetic modelling in drug development: current status and future directions; Clin Pharmacokinet; 50(8); 483–491.
Priyanka Banerjee, Andreas O Eckert, Anna K Schrey, and Robert Preissner (2018) ; ProTox-II: a webserver for the prediction of toxicity of chemicals, Nucleic Acids Res ; 46(W1); W257–W263.
Pugazhendhi .D, Umamaheswari T.S (2013); In silico Methods in Drug Discovery - A Review; International Journal of Advanced Research in Computer Science and Software Engineering; 3(5); 680-683
Raina, H., Soni, G., Jauhari, N., Sharma, N., Bharadvaja, N (2014); Phytochemical importance of medicinal plants as potential sources of anticancer agents; Turkish Journal of Botany; 38(6); 1027-1035.
Raskin, I., Ribnicky, D., Komarnytsky, S., Ilic, N., Poulev, A., Borisjuk, N., Brinker, A., Moreno, A., Ripoll, C., Yakoby, N., Cornwell, T., Pastor, I. and Fridlender, B (2002) ; Plants and human health in the twenty-first century; Trends In Biotechnology; 20(12); 522-31
Singh S, Singh J (1993) ; Transdermal drug delivery by passive diffusion and iontophoresis: a review. Med Res Rev; 13(5); 569–621.
Srimai V, Ramesh M, Parameshwar KS, Parthasarathy T (2013); Computer-aided design of selective cytochrome P450 inhibitors and docking studies of alkylresorcinol derivatives; Med Chem Res; 22(11); 5314–23.
Testa, B. & Kraemer, S. D (2007); The Biochemistry of Drug Metabolism An Introduction Testa Chemistry & Biodiversity; Wiley Online Library; 4(9); 2031-2122
Trott O., Olson A.J (2010) ; AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading; J. Comput. Chem; 31(2); 455-461.
UNECE (United Nations Economic Commission for Europe) (2011) Globally Harmonized System of Classification and Labelling of Chemicals (GHS). 4th Rev. New York: United Nations;. http://www.unece.org/fileadmin/DAM/trans/danger/publi/ghs/ghs_rev04/English/ST-SG-AC10-30-Rev4e.pdf
Van de Waterbeemd H (2002) High throughput and in silico techniques in drug metabolism and pharmacokinetics; Curr. Opin. Drug Disc. Dev; 5 (1); 33–43.
Veber D.F., Johnson S.R., Cheng H.Y.et al (2002) Molecular properties that influence the oral bioavailability of drug candidates; J.Med.Chem; 45(12); 2615–2623
Von Maydell H (1990); Trees and shrubs of the Sahel : their characteristics and uses; Weikersheim : Verlag Josef Margraf, Scientific Books; Schriftenreihe der Deutschen Gesellschaft für Technische Zusammenarbeit
Zekri A, Lesan V, Ghaffari S.H, Tabrizi M.H, Modarressi M.H (2012) ; Gene amplification and overexpression of Aurora-C in breast and prostate cancer cell lines; Oncol Res; 20(5-6); 241-250